Skip to main content

Allan Jonathan's Form 4 filing

Stoke Therapeutics, Inc. (STOK) · filed Dec 3, 2025

Accession no.
0001966716-25-000006
Filed
Dec 3, 2025
Trade date
Dec 1-3, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $138.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Allan JonathanCIK 0001966716Officer (GENERAL COUNSEL & CORP SEC)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 1, 2025Common StockMOption exerciseAcquired+12,357$0.00$024,188Direct
Dec 2, 2025Common StockSSaleDisposed−1,416$29.56−$41,856.9622,772Direct
Dec 2, 2025Common StockSSaleDisposed−868$30.14−$26,161.5221,904Direct
Dec 3, 2025Common StockSSaleDisposed−898$30.34−$27,245.3221,006Direct
Dec 3, 2025Common StockSSaleDisposed−1,394$30.85−$43,004.919,612Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 1, 2025Common StockMOption exerciseDisposed−12,357$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)